Literature DB >> 11097395

Acquired cystic kidney disease.

P L Choyke1.   

Abstract

Acquired cystic kidney disease (ACKD), also known as acquired renal cystic disease (ARCD,) occurs in patients who are on dialysis for end-stage renal disease. It is generally accepted that ACKD develops as a consequence of sustained uremia and can first manifest even before dialysis is initiated while the patient is still in chronic renal failure. The role of immune suppression, particularly in transplant recipients, in the development of ACKD, is still under investigation. The prevalence of ACKD is directly related to the duration of dialysis and the risk of cancer is directly related to the presence of cysts. Herein we review the current understanding of the pathophysiology and imaging implications of ACKD.

Entities:  

Mesh:

Year:  2000        PMID: 11097395     DOI: 10.1007/s003300000601

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  18 in total

1.  Genomic profiling of renal cell carcinoma in patients with end-stage renal disease.

Authors:  Toru Inoue; Keiko Matsuura; Taichiro Yoshimoto; Lam Tung Nguyen; Yoshiyuki Tsukamoto; Chisato Nakada; Naoki Hijiya; Takahiro Narimatsu; Takeo Nomura; Fuminori Sato; Yoji Nagashima; Kenji Kashima; Shingo Hatakeyama; Chikara Ohyama; Kazuyuki Numakura; Tomonori Habuchi; Masayuki Nakagawa; Masao Seto; Hiromitsu Mimata; Masatsugu Moriyama
Journal:  Cancer Sci       Date:  2012-01-20       Impact factor: 6.716

Review 2.  Ciliary dysfunction in polycystic kidney disease: an emerging model with polarizing potential.

Authors:  Robert J Kolb; Surya M Nauli
Journal:  Front Biosci       Date:  2008-05-01

Review 3.  Acquired cystic kidney disease: an under-recognized condition in children with end-stage renal disease.

Authors:  Eugene Y H Chan; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2017-04-25       Impact factor: 3.714

4.  Incidental Detection of Peri-Renal Hemorrhage on F-18 FDG PET/CT Imaging in a Patient with Polycystic Kidney Disease.

Authors:  Myoung Hyoun Kim; Dae-Weung Kim
Journal:  Nucl Med Mol Imaging       Date:  2018-02-01

Review 5.  Current Challenges in Diagnosis and Assessment of the Response of Locally Advanced and Metastatic Renal Cell Carcinoma.

Authors:  Alberto Diaz de Leon; Ali Pirasteh; Daniel N Costa; Payal Kapur; Hans Hammers; James Brugarolas; Ivan Pedrosa
Journal:  Radiographics       Date:  2019-06-14       Impact factor: 5.333

6.  Peroxiredoxins, thioredoxin, and Y-box-binding protein-1 are involved in the pathogenesis and progression of dialysis-associated renal cell carcinoma.

Authors:  Fumiyoshi Fushimi; Kenichi Taguchi; Hiroto Izumi; Kimitoshi Kohno; Michihiko Kuwano; Mayumi Ono; Yutaka Nakashima; Tetsuro Takesue; Seiji Naito; Yoshinao Oda
Journal:  Virchows Arch       Date:  2013-08-02       Impact factor: 4.064

Review 7.  Renal cell carcinoma: Evolving and emerging subtypes.

Authors:  Suzanne M Crumley; Mukul Divatia; Luan Truong; Steven Shen; Alberto G Ayala; Jae Y Ro
Journal:  World J Clin Cases       Date:  2013-12-16       Impact factor: 1.337

8.  A case of bilateral renal cell carcinoma associated with long-term dialysis showing false-positive immunoreactivity for TFE3 as Xp11 translocation renal cell carcinoma.

Authors:  Aiko Kurisaki-Arakawa; Tsuyoshi Saito; Michiko Takahashi; Keiko Mitani; Yuki Fukumura; Yoji Nagashima; Pedrum Argani; Takashi Yao
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

9.  Clinical outcome of incidentally discovered small renal cell carcinoma after delayed surgery.

Authors:  Koichi Sugimoto; Nobutaka Shimizu; Takashi Oki; Kazuhiro Nose; Tsukasa Nishioka; Shogo Adomi; Takayuki Ohzeki; Atsunobu Esa; Hirotsugu Uemura
Journal:  Cancer Manag Res       Date:  2013-05-24       Impact factor: 3.989

10.  Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy.

Authors:  Grzegorz Kade; Arkadiusz Lubas; Lubomir Bodnar; Cezary Szczylik; Zofia Wańkowicz
Journal:  Contemp Oncol (Pozn)       Date:  2012-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.